ALCON ATROPINE 1 %
ATROPINE SULFATE : 1 % · DIN 00035017 · ALCON CANADA INC
Health Canada status: MARKETED
What is ALCON ATROPINE?
ALCON ATROPINE 1 % contains ATROPINE SULFATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 00035017, held by ALCON CANADA INC, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 11-Sep-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00035017 |
|---|---|
| Brand name | ALCON ATROPINE |
| Generic / active ingredient | ATROPINE SULFATE : 1 % |
| Manufacturer | ALCON CANADA INC |
| Strength | 1 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01FA01 ATROPINE |
| AHFS class | 52:24.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Sep-2023 |
| Original market date | 1964-12-31 00:00:00 |
Is ATROPINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by PFIZER CANADA ULC, last seen 20 Apr 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01FA01 ATROPINE. 3 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATROPINE | 1 % | SOLUTION | PHARMA STULLN INC. | MARKETED | DIN 02023695 |
| MINIMS ATROPINE SULPHATE | 1 % | DROPS | BAUSCH & LOMB INC | MARKETED | DIN 02148358 |
| ATROPINE 1% | 1 % | DROPS | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 01948598 |
| ATROPINE ONT 1% | 1 % | OINTMENT | ALCON CANADA INC | CANCELLED POST MARKET | DIN 00252484 |
| ATROPINE SULPHATE 1% - LIQ OPH | 1 % | LIQUID | RIVEX OPHTHALMICS INC. | CANCELLED POST MARKET | DIN 02212951 |
| ATROPISOL | 10 MG | DROPS | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02134853 |
| ATROPISOL OPH SOLN 1% | 1 % | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00759929 |
| ODAN-ATROPINE | 0.35 % | DROPS | ODAN LABORATORIES LTD | DORMANT | DIN 00622907 |
| R.O.-ATROPINE | 1 % | LIQUID | RICHMOND PHARMACEUTICALS INC. | CANCELLED POST MARKET | DIN 01901311 |
Who else supplies ATROPINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ATROPINE appears in 1388 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.